(CCLD) CareCloud - Ratings and Ratios

CareCloud, Inc. (NASDAQ:CCLD) is a healthcare information technology company offering a comprehensive suite of cloud-based solutions and business services to healthcare providers and hospitals in the United States. The company operates through two primary segments: Healthcare IT and Medical Practice Management. Its product portfolio includes technology-enabled business solutions, cloud-based software, digital health services, healthcare IT professional services, and medical practice management services. Key offerings encompass revenue cycle management, claims clearinghouse, medical coding, credentialing, electronic health records, practice management software, patient experience solutions, business intelligence, healthcare analytics, AI-powered tools like CareCloud cirrusAI, chronic care management, remote patient monitoring, telemedicine, and professional consulting services. The company also provides medical practice management services, including facilities, equipment, support staff, and financial advisory services. Formerly known as MTBC, Inc., CareCloud rebranded in March 2021 and is headquartered in Somerset, New Jersey, with operations dating back to 1999.

From a technical perspective, CCLD is currently trading at $3.12 with a 20-day average volume of 94,100 shares. The stocks short-term trend indicates weakness, with the 20-day SMA at $3.73 and 50-day SMA at $3.55, both above the current price. The 200-day SMA at $2.84 suggests the stock is in a longer-term uptrend but has recently pulled back. The ATR of $0.32 indicates moderate volatility. Fundamental analysis shows a market cap of $52.67M, a forward P/E of 3.68, and a P/S ratio of 0.47, signaling undervaluation relative to peers. However, the negative RoE of -84.15% raises concerns about profitability.

3-Month Forecast: Based on , CCLD may face near-term headwinds as the stock price is below its 20-day and 50-day SMAs, suggesting continued selling pressure. The ATR of $0.32 indicates potential price swings, with support near $2.84 (200-day SMA). On the upside, a breakout above $3.73 could signal a trend reversal. From a perspective, the companys low P/S ratio of 0.47 and forward P/E of 3.68 suggest potential upside if operational efficiency improves. However, the negative RoE of -84.15% indicates significant profitability challenges that could weigh on the stock in the near term.